Standout Papers

Phase II Trial of Sorafenib in Advanced Thyroid Cancer 2008 2026 2014 2020 526
  1. Phase II Trial of Sorafenib in Advanced Thyroid Cancer (2008)
    Vandana G. Abramson, Andrea B. Troxel et al. Journal of Clinical Oncology

Immediate Impact

5 from Science/Nature 103 standout
Sub-graph 1 of 19

Citing Papers

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
37 intermediate papers

Works of Anoma Nellore being referenced

Daptomycin-Resistant Enterococcus Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation
2022
Phase II Trial of Sorafenib in Advanced Thyroid Cancer
2008 Standout

Author Peers

Author Last Decade Papers Cites
Anoma Nellore 229 193 75 413 283 38 1.1k
Khaled O. Alsaad 208 313 68 83 314 47 1.2k
Galen Cortina 131 348 56 98 238 33 1.4k
Gregory A. Hosler 69 248 326 85 271 54 1.1k
Diane Brown 104 287 55 50 320 40 1.2k
Wellington Jao 124 242 84 86 255 28 899
Gunnar Bendixen 49 206 589 213 100 33 1.4k
Marie‐Alexandra Alyanakian 94 148 538 66 84 33 1.3k
John G. Howe 274 365 183 61 798 35 1.3k
Wanlu Cao 145 274 268 79 234 29 1.1k
F Isnard 134 165 87 59 286 43 944

All Works

Loading papers...

Rankless by CCL
2026